The inositol 1,4,5-trisphosphate receptor (IP 3 R) is an intracellular ion channel that mediates the release of calcium ions from the endoplasmic reticulum. It plays a role in basic biological functions, such as cell division, differentiation, fertilization and cell death, and is involved in developmental processes including learning, memory and behavior. Deregulation of neuronal calcium signaling results in disturbance of cell homeostasis, synaptic loss and dysfunction, eventually leading to cell death. Three IP 3 R subtypes have been identified in mammalian cells and the predominant isoform in neurons is IP 3 R type 1. Dysfunction of IP 3 R type 1 may play a role in the pathogenesis of certain neurodegenerative diseases as enhanced activity of the IP 3 R was observed in models of Huntington's disease, spinocerebellar ataxias and Alzheimer's disease. These results suggest that IP 3 R-mediated signaling is a potential target for treatment of these disorders. In this review we discuss the structure, functions and regulation of the IP 3 R in healthy neurons and in conditions of neurodegeneration.
Introduction
Inositol 1,4,5-trisphosphate receptors (IP 3 Rs) are a family of intracellular ion channels that mediate calcium (Ca 2+ ) release from the endoplasmic reticulum (ER) following stimulation by the second messenger inositol 1,4,5-trisphosphate (IP 3 ). Generation of IP 3 molecules is caused by the activation of phospholipase C in response to the activation of G proteincoupled receptors such as serotonergic receptors, adrenergic receptors, calcitonin receptors, histamine receptors, metabotropic glutamate receptors (mGluRs), Abbreviations AAV, adeno-associated virus; AD, Alzheimer's disease; ALG-2, apoptosis-linked gene 2; ARM, armadillo; Ab, beta amyloid; BH, Bcl-2 homology; CaBP1, calcium-binding protein 1; CTD, C-terminal domain; EM, electron microscopy; ER, endoplasmic reticulum; FAD, familial Alzheimer's disease; GRP78, 78-kDa glucose regulated protein; HAP1, huntingtin-associated protein 1; HD, Huntington's disease; HelD, helical domain; Htt, huntingtin; IBC, IP 3 -binding core; IICR, inositol 1,4,5-trisphosphate-induced calcium release; ILD, 'intervening lateral' domain; IP 3 , inositol 1,4,5-trisphosphate; IP 3 R1, IP 3 R type 1; IP 3 R, inositol 1,4,5-trisphosphate receptor; IRBIT, IP 3 R binding protein released with IP 3 ; KO, knock-out; LBD, ligand-binding domain; LNK, helical linker domain; MCI, mild cognitive impairment; mGluR, metabotropic glutamate receptor; mPTP, mitochondrial permeability transition pore; MSN, medium spiny neuron; NMDA, N-methyl-D-aspartate; NTR, Nterminal region; Opt, opisthotonos; PC, Purkinje cell; polyQ, polyglutamine; PS, presenilin; RyR, ryanodine receptor; SAD, sporadic Alzheimer's disease; SCA, spinocerebellar ataxia; SD, IP 3 -binding suppressor domain; SUMF1, sulfatase modifying factor 1; TG2, transglutaminase type 2; TMD, transmembrane domain; WT, wild-type; YAC, yeast artificial chromosome; b-TF, b-trefoil. muscarinic receptors, and many others [1] (Fig. 1) . Upon extracellular stimulation -by various agonists such as hormones, neurotransmitters, growth factors, odorants and neurotrophins -phospholipase C cleaves the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into the secondary messenger molecules diacylglycerol (DAG) and IP 3 (Fig. 1) . DAG remains bound to the membrane, and soluble IP 3 is released into the cytosol. IP 3 then binds to the IP 3 R and this leads to IP 3 R-induced Ca 2+ release (IICR) from the ER (Fig. 1) , causing an increase in the cytosolic Ca 2+ concentration, which leads to a cascade of intracellular responses and influences the activity of various proteins and enzymes [2] . Thus, IP 3 Rs play a key role in cell signaling by transforming extracellular molecular signals into intracellular signals [3] . It was recently shown that IICR is initiated at numerous immobile sites and more intense stimulation increases the probability of a site initiating a calcium puff without increasing the underlying number of competent calcium release sites [4] .
Electrophysiological, biochemical and direct structure determination methods have revealed the structure and function of the IP 3 R. Cell biological and biochemical studies have shown that IP 3 Rs are involved in the regulation of basic biological functions, including cell division, differentiation, fertilization, development and cell death, and play a role during developmental processes, such as learning, memory and behavior [5] .
There is evidence to suggest that disturbed calcium signaling in neurons may play a key role in the pathogenesis of neurodegenerative disorders such as Huntington's disease (HD), spinocerebellar ataxias (SCAs) and Alzheimer's disease (AD). Experiments using HD and SCA types 2 and 3 (SCA2 and SCA3) transgenic mouse models have supported a link between deregulation of calcium signaling and neuronal cell death [6] . Deregulation of calcium signaling in neurons may also play a role in the pathogenesis of SCA types 15/16 and 29 (SCA15/16 and SCA29), Gillespie's syndrome, sensory ataxia and some other neurodegenerative disorders (Table 1 ). These data indicated that IICR might be one of the causes of pathophysiological events in neuronal cells [7, 8] .
There are three IP 3 R isoforms present in all types of mammalian cells. This review is devoted mainly to IP 3 R type 1 (IP 3 R1) because it is the predominant isoform in neurons and the best studied isoform. We will first highlight the studies that report the structure and function of IP 3 Rs and then discuss the role of the IP 3 R in several neurodegenerative disorders. IP 3 Rs represent a potentially valuable drug target for the treatment of these disorders and for modulating the activity of neurons and other cells.
Identification of IP 3 Rs
The IP 3 -binding protein was initially purified from rat cerebellum by S. H. Snyder's research team in 1988. In this study the purified receptor was observed as a band of 260 kDa on polyacrylamide gel electrophoresis under denaturing conditions [9] . Using antibodies directed against a purified IP 3 R, immunocytochemical studies in rat cerebellar Purkinje cells (PCs) showed that the IP 3 R was localized on the ER membrane, on the portion of subplasmalemmal cisternae and on the nuclear membrane, but not in the mitochondria or on the plasma membrane. The authors concluded that IICR in cerebellar PCs is based not only on the activities of receptors localized to a single organelle, but on the coordination of receptor activities of both rough and smooth ER, and possibly by other smooth surfaced cellular structures that include IP 3 R molecules [10] .
The primary sequence of mouse IP 3 R1 was determined in 1989 by K. Mikoshiba's group. Previously their studies had revealed PC degeneration in mutant mice that had very low expression of a glycoprotein called P400 [11] . Cloning and expression of functional P400 protein from cerebellar PCs have shown that this protein is a receptor for IP 3 , a second messenger that mediates the release of intracellular calcium [12] . At the same time, T. C. Sudhof's group determined the partial and complete sequence of rat IP 3 R1 following functional analysis of PC-specific protein PCD6 [13, 14] .
The three genes that encode the three IP 3 R subtypes, IP 3 R1, IP 3 R2 and IP 3 R3, have been identified and cloned in mammalian cells [15] . 41 and 42 [20] . Also, receptor diversity can result from hetero-oligomeric interactions between various IP 3 R isoforms. Immunoprecipitation using isoform-specific antibodies showed that distinct types of IP 3 R subunits assemble to form homo-and heterotetramers [21] .
Structure, function and regulation of IP 3 Rs
The three mammalian IP 3 R isoforms contain 2700-2800 amino acid residues and share 60-70% sequence [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] identity and a common domain structure [22] . Recently the near-atomic (4.7 A) resolution cryo-electron microscopy (cryo-EM) structure of unbound IP 3 R1 purified from rat cerebellum was reported by Serysheva's group [23] . Each IP 3 R1 subunit consists of 10 domains ( Fig. 2A) , which are organized in tetrameric structure around a central four-fold axis forming the ion-permeation pathway (Fig. 3A) . The IP 3 R protein has a large cytosolic domain that represents about 90% of the protein sequence and includes the N-terminal region (NTR) and C-terminal tail (Fig. 2A) . The remaining regions are transmembrane and luminal domains. At the NTR of each subunit, two adjacent b-trefoil domains (b-TF1 and b-TF2; residues 1-436) form apical densities around the central four-fold axis of the cytosolic region. After the b-TF2 domain, there are three consecutive a-helical domains (HelDs; ARM1-ARM3, residues 437-2192) formed by ensembles of armadillo (ARM) solenoid folds with the HelD (residues 715-1029) between ARM1 (residues 436-604) and ARM2 (residues 1030-1494) [23] (Fig. 2A) recognition and binding of different modulatory proteins (Fig. 2B) [24]. The first two ARM repeats of the ARM1 and the two preceding b-TF domains form the ligand-binding domain (LBD; Fig. 2A ). The b-TF1 domain (residues 5-225) was named the IP 3 -binding suppressor domain (SD), and the b-TF2 (residues 226-435) with two a-helices of ARM1 represent the IP 3 -binding core (IBC) domain ( Fig. 2A) , also divided into b-IBC and a-IBC subdomains, accordingly. After ARM3 (residues 1594-2192), the subunit extends into the 'intervening lateral' domain (ILD; residues 2193-2272) that contains two anti-parallel b-strands followed by a helix-turn-helix motif. The C terminus of the ILD is connected to the transmembrane region, comprising six a-helices (TM1-TM6), a pore (P)-helix and three lumenal loops (23). The C-terminal domain (CTD) contains an a-helix (residues 2681-2731) connected at its NTR to TM6 via a helical linker domain (LNK; residues 2601-2680; Fig. 2A ).
The central core of IP 3 R1 is formed by one transmembrane and one cytosolic four-helix bundle connected via four-two-helix LNK domains (Fig. 3A) . The transmembrane bundle contains four TM6 helices and the cytosolic bundle is formed by four CTD ahelices, one helix from each of four subunits. A bundle of TM6 helices including a series of hydrophobic residues shape the calcium permeation pathway (Fig. 3A) . The cytosolic part of this TM6 bundle has negatively charged residues and may facilitate the transport of calcium ions into the cytosol. The TM5 helices are located against the TM6 helices forming the central bundle. TM5 and TM6 are connected by the lumenal loop containing a short P-helix (residues 2531-2544) and a conserved selectivity filter (residues 2546-2552). There is a possibility that the P-helices may be affected by a structural rearrangement during the open state of the channel [23] . The central bundle is connected to the flanking TM1-TM4 bundle via an amphipathic ahelix (TM4-5), which is located parallel to the cytosolic membrane leaflet [23] . The possible function of the TM4-5 helix is the control of the movements of the pore-lining helices of the IP 3 R [25] . The SD and the IBC of each subunit make up triangular structure [23, 26] . The four LBDs form a cytoplasmic apical density around the CTD bundle [23] . The ARM2 (10 ARM repeats), ARM3 (six ARM repeats) and HelD link the IBC domain with the channel-forming region.
The IP 3 R channel gating can be regulated by various intracellular factors. Generally, the regulation of IP 3 R activity is complex, but the main modulators are IP 3 ( Fig. 2A) and calcium (Fig. 2B) [16, 27] . IP 3 molecules bind to the NTR of the IP 3 R and calcium ions to the middle coupling region. Two basic models of IP 3 R gating by IP 3 molecules were proposed: direct binding between IBC/SD domains and the central pore domain [28] , and long-distance coupling from the IBC to the channel [29, 30] . Recent cryo-EM analysis of IP 3 R1 has revealed that the IBC is located about 79 A from the calcium conducting pore and directly interacts with the CTD through a long helical bundle connecting to the pore-forming TM6 [23] . The cryo-EM structure also suggests that IP 3 R gating has several different initiation points that mechanically couple intracellular signals to a common ion-conduction pathway conserved in many ion channels [23] . Previous experiments on crystallization of the LBD, solved in both the IP 3 -bound and unbound states [26, 31] The recently published results of crystallographic analysis of IP 3 R1 provided low-resolution (6-8 A) structures and confirmed the cryo-EM findings about IP 3 R1 structure [36] . With the use of channel mutagenesis and X-ray crystallography of the large cytosolic domain of mouse IP 3 R1 in apo and holo states, the long-range gating mechanism was identified [36] . An IP 3 -dependent conformational change is transmitted from the IBC to the calcium permeation pathway through a-helices forming ARM1, HelD and ARM3 domains containing the leaflet region. Mutation analyses of the leaflet region revealed important roles of both residues facing the cytosolic domain and residues facing the central four-fold axis [36] . It is noteworthy that the leaflet structure [36] corresponds to the first two strands of the ILD observed in the full tetrameric IP 3 R1 channel [23] . Thus, the authors supported the mechanism of signal transduction through the ILD-LNK interface originally proposed by Fan et al. [23] .
In addition to calcium and IP 3 there are other allosteric IP 3 R modulators, including ATP (Fig. 2B ), that interact with the IP 3 R [16, 24] . Study of the outer membrane of isolated Xenopus laevis oocyte nuclei has revealed that the fungal metabolite adenophostin (Ada) A and its analogs are also potent agonists of the IP 3 R (Fig. 2B) [37]. Recently, a rapid, sensitive and flexible way for measuring IP 3 concentrations in the cytosol, termed competitive fluorescent ligand assay, was designed using a fluorescent Ada A analog [38] .
The negative regulation of IP 3 R gating may be caused by the presence of calcium-binding protein 1 (CaBP1), a neuron-specific member of the calmodulin (CaM) superfamily (Fig. 2B ). Nuclear magnetic resonance paramagnetic relaxation enhancement analysis has shown that the C lobe of CaBP1 binds to the cytosolic NTR (residues 1-604) of IP 3 R1 by means of hydrophobic interactions. Docking analyses and paramagnetic relaxation enhancement of structural restraints demonstrated that CaBP1 formed a ring around the cytosolic entrance of the IP 3 R, stabilizing interactions between NTRs of tetrameric IP 3 R. Thus, the authors concluded that CaBP1 inhibits IP 3 R activity by clamping the intersubunit movements and thereby stabilizing the closed state of the channel [39] . The other protein that suppresses IP 3 R activity is IP 3 R binding protein released with IP 3 (IRBIT; Fig. 2B ). IRBIT suppresses IP 3 R activation through competition with IP 3 for the common binding site on the IP 3 R [40] .
Recently the apoptotic regulator Bcl-2 protein family member Bok was reported as a novel component of IP 3 R complexes (Fig. 2B ) [41] . Bcl-2-related proteins are localized to the ER [42] , bind to the IP 3 Rs [43] and regulate the ER-mediated cell viability via IICR modulation [44] . Recent studies have shown that the Bcl-2 homology (BH) 4 domain of Bok binds constitutively to the residues 1895-1903 of the coupling domain of the IP 3 R and this binding is very potent (Fig. 2B) . Bok protected the IP 3 R from proteolysis both in vitro and in vivo during apoptosis [41] . Another Bcl-2 family member, Bcl-x L , was found to modulate single IP 3 R channels with biphasic concentration dependence. The BH3 domain of Bcl-x L binds two BH3 domain-like helices, H1 and H4, in the C terminus of the IP 3 R (Fig. 2B ) leading to IP 3 R gating activation [45] . Helix H1 represents residues 2571-2606 and helix H4 represents residues 2690-2732 in the IP 3 R1 sequence [45] . According to cryo-EM data, the proposed H1 BH3 motif of IP 3 R1 represents most of the TM6 a-helix together with the first a-helix from the LNK domain while the proposed H4 BH3 motif represents the a-helix in the CTD [23] . Sequence alignment of BH3 domains from Bcl-2-related proteins has revealed conserved BH3-like sequences in both H1 and H4 [45] . Gating inhibition is observed when Bcl-x L binds to one BH3 domain-like helix and to a previously identified Bcl-2 interaction site in the coupling domain of the IP 3 R. Disruption of these interactions provokes apoptosis and reduces the viability of cells [45] . The activity of IP 3 R can also be regulated by phosphorylation by different kinases [16, 27] . Among them cAMP-dependent protein kinase (PKA), protein kinase C, cGMP-dependent protein kinase (PKG), Ca 2+ /CaM-dependent protein kinase II (CaMKII) and different protein tyrosine kinases (Fig. 2B) . Moreover, the IP 3 R might also be regulated by redox status and interacting proteins [16] .
The activation of the IP 3 R leads to calcium release from the ER and, as a consequence, to an increase in the intracellular calcium concentration. In neurons this process can affect various cellular activities such as cell proliferation, differentiation, cell development, gene expression, apoptosis, neurotransmission and synaptic plasticity [46] . Behavioral experiments revealed that IP 3 Rs are involved in memory formation; in particular, they are required for long-term memory [47] . Recently, Mikoshiba's research group has shown that the IP 3 R1 in cerebellar PCs plays a crucial role in controlling the maintenance of parallel fiber-PC synaptic circuits in the mature cerebellum in vivo [48] . Also, it has been shown that IP 3 R1, together with other important intracellular proteins, plays a significant role in PC dendritic development [49] . Thus, proper regulation of IP 3 R activity is necessary for normal brain development and function.
Mutations in the IP3R1 gene and ataxias
The physiological function of the IP 3 R has been investigated using IP 3 R transgenic animals. Previous experiments have shown that most IP 3 R1 knock-out (KO) mice did not survive the period of prenatal development [50] . The surviving IP 3 R1-KO mice displayed severe ataxia and tonic-chronic seizures and died by the age of 3-4 weeks. An electroencephalographic study of these mice confirmed that they suffer from epileptic symptoms. Continuous electroencephalographic recordings of IP 3 R1-KO mice have shown paroxysmal polyspike activities, whereas only stable background activities were observed in control mice [50] . However, histological examination and microscopic investigation of the brain slices and peripheral tissues of IP 3 R1-deficient mice have not revealed any apparent pathology [50] . Further, electrophysiological studies performed in mice with disrupted IP3R1 gene demonstrated impairment of the cerebellar long-term depression form of synaptic plasticity at the parallel fiber-PC synapse [51] .
The IP 3 R's functions were also studied using opisthotonos (opt) mice and D18 mice. The opt mutation represents a spontaneous mutation that arose in a C57BL/Ks-db 2J mice colony. These mutant mice display some features of an ataxic and convulsive phenotype. Genetic data showed that the IP3R1 gene is modified in the opt mice [52] . A partial deletion of IP3R1 removes two exons but does not interrupt the translational reading frame. The expression of the altered protein was significantly reduced in opt homozygotes, most likely because of the instability of the mutant IP 3 R1 protein. The altered protein was also predicted to have lost several modulatory sites. The calcium response to mGluR 1 activation by quisqualate is reduced in PCs from opt homozygotes when compared with control mice with the same quisqualate treatment. Thus, it was concluded that the distinctive ataxia and convulsion phenotype, typical for opt mice, are likely to be caused by the disturbed function of IP 3 R1 [52] . Furthermore, using the Spodoptera frugiperda cell expression system and planar lipid bilayers, the recombinant predominant neuronal isoform of IP 3 R1, named IP 3 R1-SII(+), was compared with non-neuronal isoform IP 3 R1-SII(À), and IP 3 R1-opt channel. These results showed that the IP 3 R1-opt channel is functional, but it has a lower conductance and much lower ATP-binding (ATP) activity when compared with the wild-type (WT) IP 3 R1 [53] . Thus, it was concluded that the pathological phenotype of opt mice is caused primarily by reduction of IP 3 R1 expression levels.
In D18 mice an in-frame deletion of 18 base pairs within the exon 36 of the IP3R1 gene occurs that results in the deletion of residues 1533-1538 in the regulatory domain [54] . To study the role of this deletion, heterozygous D18 mice were crossed with heterozygous opt mice. The phenotype of IP3R1 opt/D18 mice was similar to that of the homozygous D18 mice, opt mice and IP 3 R1-KO mice. Similar to the homozygous opt mice, the in-frame deletion of residues 1533-1538 in the middle coupling domain of D18 mutants resulted in significant reduction of IP 3 R1 expression in cerebellar PCs [54] . The D18 mutant mice may be used as a valuable mouse model for SCA15/16 [55] .
Alterations in IP 3 R1 function appear to play a significant role in human ataxias (Table 1) [56, 57] . The first SCA15 case was identified in 2001 as a rarely occurring slow progressive autosomal dominant ataxia. The distinguishing feature of this disorder is head tremor. In SCA15 patients, the atrophy of the cerebellum (especially anterior and dorsal vermis) is observed. The locus for SCA15 was mapped to various deletions of the IP3R1 gene on the distal short arm of chromosome 3 [58] [59] [60] [61] . SCA16 is also caused by the IP3R1 gene mutation, and this autosomal dominant cerebellar ataxia subtype has now been merged with SCA15 [62] . The genetic defects in SCA15 were identified in families from Australia, Japan and the UK. The partial deletions including both the IP3R1 gene and the sulfatase modifying factor 1 (SUMF1) gene have been detected in Australian and British families with SCA15 [54] . The research team from Japan described a 414 kb deletion including the whole IP3R1 gene and exon 1 of SUMF1 in SCA15 patients from the same family. This mutation led to the reduction of expression levels of IP3R1 and SUMF1 mRNAs (approximately two-fold lower). Thus, in some cases IP3R1 may represent the genetic basis of SCA15 [63] . A British research group identified no IP3R1 gene mutations in the study on unrelated autosomal dominant cerebellar ataxia III families (n = 38). The results obtained suggested that point mutations or deletions in the IP3R1 gene are a rare cause of SCA15/ 16 [58] . In support of this it was found that IP3R1 gene deletions are infrequent and cause about 1% of all autosomal dominant cerebellar ataxia [64] .
All of the above refers to subjects of continental western European origin. However cases of SCA15/16 also have been detected in Japan. In 2010 a Japanese family with slowly progressive SCA was found. Detailed clinical, genetic and radiological description of their genotype revealed mutations in the IP3R1 gene and serial magnetic resonance imaging showed moderate cerebellar atrophy with mild inferior parietal and temporal cortical volume loss [61] . Genetic analysis of these patients revealed a deletion of 346 487 bp in the IP3R1 gene. Western blotting of the lymphoblastoid cell line protein confirmed reduced IP 3 R1 protein levels. Thus, this study confirmed that SCA15 is a slowly progressive ataxia, which is caused by a reduction in expression levels and partial loss of IP 3 R1 function. The authors concluded that patients afflicted with non-progressive or slowly progressive SCA should be screened for mutations in the IP3R1 gene [61] .
Recently, a pathogenic gain-of-function missense mutation within the SD of IP 3 R1 was reported to cause SCA29 without cerebellar atrophy or other neuroimaging abnormalities. The mutant IP 3 R1 showed a significantly higher IP 3 -binding activity than observed in WT IP 3 R1 case, and thus promoted the enhanced calcium release in SCA29 patients [65] .
Novel pathological mutations of IP 3 R1 were recently found in seven patients from four families that represented about 16.8% of the total number of patients with congenital cerebellar and/or vermis atrophy taking part in a survey. All these mutations were localized in the IBC domain [66] . Recently heterozygous IP3R1 missense mutations were found in four unrelated patients with sporadic infantile-onset SCA from among 60 families with SCA. Three of these mutations were localized in the LBD and one in the IBC domain of IP 3 R1 [67] .
Gillespie's syndrome is characterized by iris hypoplasia, mild to moderate intellectual disability and aniridia that can be associated with cerebellar ataxia. Recently de novo missense mutations in the IP3R1 gene were detected in five families with Gillespie's syndrome and these mutations were located mainly in the TMD of IP 3 R1 [68] (Table 1) . New pathological mutations were identified in two other families with Gillespie's syndrome. These mutations were localized also in the TMD of IP 3 R1, representing a recurrent deletion and a novel missense mutation next to the hydrophobic residue within a constriction region of the channel pore. The authors concluded that IP3R1 gene screening should be done in patients with congenital cerebellar ataxia with or without iris hypoplasia [69] .
It is noteworthy that not only mutations in the IP3R1 gene but also mutations in genes encoding proteins of the IP 3 R1 signaling pathway may cause ataxia. For example, autosomal dominant sensory ataxia, a neurodegenerative disorder characterized by the destruction of the posterior columns of the spinal cord, is caused by a point mutation in the ER membrane ubiquitin ligase RNF170, which participates in the ubiquitination of activated IP 3 R. Recent studies have revealed that the disease-causing point mutation in RNF170 disrupts salt bridges between its TMD, which provokes RNF170 destabilization and leads to IICR inhibition [70] .
Inositol 1,4,5-trisphosphate receptor is also involved in the pathogenesis of different types of cerebellar ataxia. Recently in the study of patients with autoimmune cerebellar ataxia, new serum autoantibodies with high specificity to PCs were detected. Via different immunological methods, IP 3 R1 was identified as the target antigen of this reactivity. Thus, it was shown that IP 3 R1 represents a diagnostic serum marker of autoimmune cerebellar ataxia [71] .
Huntington's disease
Huntington's disease is a polyglutamine (polyQ) expansion neurodegenerative disorder with autosomaldominant mode of inheritance. This disease presents itself typically during mid-life, but it can also manifest itself at any time between infancy and senescence, with a progressive dementia and abnormal movements that usually takes the form of chorea -rapid dance-like movements, typically of the hands and neck. Moreover symptoms can include dystonia, incoordination, cognitive decline and behavioral difficulties [72] . HD symptoms are caused by neuronal death, which, in turn, is caused by the presence of an expanded polyQ tract in the huntingtin (Htt) protein. This mutant Htt is detected in almost every cell type, but its toxicity affects neurons of certain areas of the brain, such as the cortex, caudate nucleus and putamen. In affected areas of the brain, mutant Htt is found not in its intact monomeric form, but in the form of N-terminal fragments, oligomers and polymers, all of which accumulate with some other proteins in the cortex. There is a suggestion that the aggregates and insoluble inclusions containing mutant Htt are toxic to neurons [73] . Up until now the biological function of WT Htt has remained unclear. There are some experimental data showing that normal Htt takes part in signal transduction in each cell type by acting to organize components of signal transduction complexes [74] .
Htt-associated protein-1A (HAP1A) was isolated by our laboratory in a yeast two-hybrid screen with the IP 3 R1 C terminus, and an IP 3 R1-HAP1A-Htt ternary complex is formed both in vitro and in vivo [75] . Experiments in planar lipid bilayers revealed that IP 3 R1 activation by IP 3 is sensitized by mutant Htt, but not by normal Htt. Furthermore, the transfection of full-length mutant Htt or caspase-resistant mutant Htt, but not normal Htt, into medium spiny striatal mice neurons facilitates Ca 2+ release in response to threshold concentrations of the selective mGluR1/5 agonist 3,5-dihydroxyphenylglycine. These findings identified a novel molecular link between Htt and IP 3 R1-mediated neuronal Ca 2+ signaling and provided a possible mechanism for the deregulation of cytosolic Ca 2+ signaling in HD [75] (Fig. 4) . Association of mutant Htt with the IP 3 R was independently confirmed in an unbiased proteomics screen [76] . Expression of the human mutant htt transgene in a Drosophila melanogaster model caused retinal degeneration and IP 3 R1 expression modified the eye pathological phenotype of mutant Htt flies; the reduction of expression of the IP 3 R1 suppressed it, whereas enhanced expression made it more severe [76] . These results are consistent with the hypothesis that mutant Htt causes abnormal activity of IP 3 R (Table 1) .
To investigate the role of HAP1 protein, experiments on transgenic mice with targeted disruption of both HAP1 alleles (HAP1 À/À ) were conducted [77] .
HAP1 is expressed in the medium spiny neurons (MSNs) and HAP1A facilitates functional effects of both normal Htt and mutant Htt on IP 3 R1 in planar lipid bilayers. HAP1 facilitates potentiation of IP 3 R1-mediated Ca 2+ release by mutant Htt in mouse MSNs [77] . In further experiments using a yeast artificial chromosome (YAC) transgenic mouse model of HD, the connection between disturbed calcium signaling and apoptosis of HD MSNs was investigated [78] . The results showed that repetitive application of glutamate elevates cytosolic Ca 2+ levels in MSNs from the YAC128 mice but not in MSNs from the WT mice. Thus, application of glutamate results in apoptosis in YAC128 MSNs but not in WT MSNs. In relation to IP 3 R1, the analysis of glutamate-induced apoptosis of the YAC128 MSNs revealed that membrane-permeant IP 3 R blockers 2-aminoethoxy diphenyl borate and enoxaparin (Lovenox) are neuroprotective (Fig. 4) and may have a therapeutic potential for treatment of HD [78] .
Mutant (mut)-Htt-IP 3 R1 association is mediated by a cytosolic C-terminal tail of IP 3 R1 (a 122 amino acid IC10 fragment). To evaluate the importance of mutHtt association with IP 3 R1 for HD pathology, lentivirus (Lenti) and adeno-associated virus (AAV) expressing GFP-IC10 fusion protein were generated, and a series of experiments with YAC128 HD transgenic mice was performed [79] . It appeared that infection with the Lenti-GFP-IC10 protein stabilized Ca 2+ signaling in cultured YAC128 MSNs and protected YAC128 MSNs from glutamate-induced apoptosis. Furthermore, intra-striatal in vivo injections of AAV1-GFP-IC10 significantly alleviated motor deficits and reduced MSN loss and shrinkage in YAC128 mice. Thus, mut-Htt-IP 3 R1 association is important for HD pathogenesis and thus IP 3 R1 is a potential therapeutic target for HD. These data also supports potential use of IC10 peptide as a novel HD therapeutic agent [79] . In further experiments, it was shown that chronically enhanced calcium leakage from YAC128 MSN ER caused a reduction in the ER calcium level and led to increased stromal interaction molecule 2-mediated store-operated calcium entry, and that resulted in the MSN spine loss both in vitro and in vivo [80] .
There are other regulatory mechanisms of IP 3 R1 activity that might possibly be used in HD therapy. IP 3 R1 tetrameric assembly is regulated by the ER chaperone 78-kDa glucose regulated protein (GRP78) and IP 3 R1-GRP78 association is impaired in the brain of HD model mice. These results suggest a role for GRP78 and ER stress in HD pathology [81] . It has been shown that vimentin type III intermediate filament sequesters IRBIT into perinuclear inclusions causing a decrease in the interaction between IRBIT and IP 3 R1 and suppression of the IP 3 binding to IP 3 R1. Enhanced IICR leads to the increased aggregation of mutant Htt. Vimentin overexpression enhanced and knock-down reduced mutant Htt aggregation. Phosphorylation of Ser71 and Ser38 residues in vimentin is mediated by rho-associated kinases. The rhoassociated kinase inhibitor Y-27632 inhibits vimentin phosphorylation and reduces the effect of vimentin on mutant Htt aggregation. Therefore, the authors suggested that the regulation of vimentin levels and phosphorylation might be a promising therapeutic strategy for HD and other polyQ disorders [82] .
The allosteric regulation in IP 3 R1 also plays an important role in the proper functioning of this receptor. Recently a new mode of permanent allosteric state of IP 3 R1 was discovered, namely the covalent modification of IP 3 R1 at Gln2746 catalyzed by transglutaminase type 2 (TG2). TG catalyses protein cross-linking between Gln and Lys residues via an isopeptide bond. Modification of Gln2746 in IP 3 R1 was observed in HD models [83] . Ablation of TG2 in HD mice led to an increase of the mouse's lifespan and motor activity improvement. Up-regulation of TG2 enhanced the Gln2746 modification of IP 3 R1, and TG2 suppressed IICR in HD. Thus, the authors proposed a potential role of this modification in causing abnormal calcium signaling in HD neurons [83] .
Spinocerebellar ataxia types 2 and 3
Similar to HD, SCA2 is a progressive, degenerative, inherited disorder caused by expanded CAG repeats encoding a long polyQ tract in the ataxin-2 protein [84] . Symptoms of SCA2 include a progressive cerebellar syndrome with ataxia of gait and stance, ataxia of limb movements, dysarthria, ophthalmoplegia, pyramidal pumped into the mitochondria (Mito) through the mitochondrial calcium uniporter (MCU), which leads to mitochondrial swelling, followed later by rupture of outer mitochondrial membrane; then pro-apoptotic factors like cytochrome c (Cyt c) come into the cytoplasm and initiate apoptosis. Hence, dramatically increased IICR can be suppressed by AAV-mediated expression of the enzyme IP 3 phosphatase (5PP), which converts IP 3 into inactive form inositol bisphosphate. Also, calcium release from ER can be reduced with the use of dantrolene, a blocker of RyRs or IP 3 R blockers 2-aminoethoxy diphenyl borate (2-APB) and enoxaparin.
and extrapyramidal disorders, muscular rigidity and other severe neurological symptoms [85] [86] [87] . To date, the pathogenesis of SCA2 is still unclear. Similar to WT ataxin-2, polyQ-expanded abnormal ataxin-2 protein is expressed in each cell type without noticeable aggregation or inclusion bodies [88] . Nonetheless, the PCs in the cerebellar cortex of SCA2 patients are highly affected with over 75% neuronal loss in the terminal stage of the disease [86] .
In our experiments on a planar lipid bilayer model system using single channel recordings of IP 3 R1 coexpressed with polyQ-expanded ataxin-2, we have shown that abnormal ataxin-2 protein (but not WT ataxin-2) binds to the CTD of the IP 3 R1 (Fig. 4) . The expression of mutant ataxin-2 significantly increased the sensitivity of IP 3 R1 to activation by IP 3 (Fig. 4 ) [89] . Further experiments on calcium imaging conducted in primary PCs cultures from SCA2-58Q transgenic and WT mice have identified the significantly enhanced IICR via IP 3 R1 in SCA2-58Q PCs, but not in WT PCs. To suppress RyRs and IICR in PC cultures, ryanodine or dantrolene was applied (Fig. 4) . The impact of polyQ-expanded ataxin-2 was abolished since, in the presence of dantrolene, IICR returned to WT levels. We suggested that dantrolene and ryanodine improved disturbed calcium signaling by suppressing Ca 2+ release induced by IICR that is enhanced by the RyR [89] . Long-term feeding of SCA2-58Q mice with dantrolene rescued motor coordination defects and alleviated loss of PC cells [89] .
To further test the hypothesis that IICR plays an important role in SCA2, the chronic suppression of IICR was attained by AAV-mediated expression of IP 3 phosphatase in SCA2-58Q PCs (Fig. 4) [90] . Patchclamp experiments on cerebellar slices showed that virus-mediated IP 3 phosphatase overexpression improved age-dependent impairment in the electrophysiological activity of SCA2 PCs. Experiments on motor activity evaluation revealed that chronic IP 3 phosphatase overexpression also alleviated age-dependent motor coordination difficulties and PC death in SCA2-58Q mice [90] . These results support the key role of deranged Ca 2+ signaling in SCA2 pathogenesis. Thus, we may conclude that partial suppression of IICR could provide therapeutic benefit for SCA2 patients and possibly for patients with other types of SCAs [7, 90] .
In a recent study we compared the functional properties of PCs from the intact cerebella of aging WT and SCA2-58Q transgenic mice using an in vivo recording technique. We observed significant and agedependent loss of firing precision of PCs in SCA2-58Q mice [91] . The reason for loss of precision firing by SCA2-58Q PCs may be due to the toxic effects of mutant ataxin-2 leading to the dysregulation of IICR [7, 57, 91] .
Spinocerebellar ataxia 3 is a neurodegenerative disease also caused by a polyQ expansion in the CTD of ataxin-3 protein [92] . SCA3 is characterized by irreversible degeneration of spinocerebellar tracts, dentate nucleus, pontine and other brainstem nuclei, substantia nigra and pallidum [93, 94] . The cerebellar atrophy is, however, less pronounced than in SCA2, but, unlike SCA2 pathogenesis, nuclear inclusions containing polyQ-expanded ataxin-3 have been found in neurons of the affected brain areas. Ataxin-3 has been associated with the ubiquitin-proteasome system and transcriptional regulation. Ataxin-3 includes three ubiquitin-interacting motifs and an N-terminal Josephin domain, which points to ataxin-3's function as a deubiquitinating enzyme. The polyQ tract has no effect on the deubiquitinating function of ataxin-3 [95] , so it may be concluded that neuropathology in SCA3 is mainly due to a gain of toxic function mediated by the expanded polyQ tract. Normal ataxin-3 binds to target DNA sequences in the promoter of the matrix metalloproteinase-2 gene and represses transcription by recruitment of histone deacetylase 3, the nuclear receptor corepressor, and deacetylation of histones bound to the promoter [96] . In transfected mouse neuroblastoma N2a and human embryonic kidney 293T cells, the aggregation of polyQ-expanded ataxin-3 could be blocked by the suppression of the Ca 2+ -dependent protease calpain [97] . Similar to polyQ-expanded Htt and mutant ataxin-2, we demonstrated that polyQexpanded ataxin-3, but not normal ataxin-3, interacts with IP 3 R1 and leads to its activation [98] (Fig. 4) . Moreover, the long-term treatment of SCA3-YAC-84Q mutant mice with the Ca 2+ stabilizer dantrolene improved age-dependent impairment of motor activity in these mice and prevented neuronal cell death in the cerebellum [98] . Similarly to SCA2 cases, these improvements can be explained by the suppression of Ca 2+ release resulting from disturbed IICR that is overextended by the RyR in neurons (Fig. 4) .
Recent studies, using mathematical methods, have shown that IP 3 R1 is required to modulate the SCA disease state. A suite of computational models was developed to study SCAs and the role of IP 3 R1 in their pathogenesis [99] . The SCA modeling suite represents a collection of compartmental and spatial models that simulate the biochemical and electrophysiological properties of the cerebellar PCs including the effect of various ion channel molecules and calcium signaling on PC functions. The models predict IP 3 R1 hypersensitivity in SCA1 and compensatory mechanisms in SCA1, SCA2 and SCA3. The study also has revealed that IICR activates voltage-gated calcium-activated potassium channels in the cell membrane. The authors concluded that the SCA modeling suite might help to characterize the cellular pathophysiology of IP 3 R1-associated cerebellar ataxia [99] .
All these studies suggest that disturbed neuronal Ca 2+ signaling mediated via IP 3 R1 may play an essential role in the pathogenesis of polyQ-expansion neurodegenerative disorders.
Alzheimer's disease
Alzheimer's disease is a widespread neurodegenerative disorder that affects primarily senior people. Symptoms mostly involve slowly developing and irreversible neurodegeneration. The etiology of AD is still under discussion, but advanced age is regarded as a principle risk factor. The main criteria of AD are accumulation of extracellular b amyloid (Ab) plaques or enhancement of the Ab 42 :Ab 40 ratio, intracellular neurofibrillary tangles and neuronal loss [100] . The most common form of AD is sporadic AD (SAD). In a small fraction of cases, autosomal dominant familial cases of the disease (familial Alzheimer's disease; FAD) manifest in middle age. FAD is caused by mutations in presenilins (PS1 and PS2) and amyloid precursor protein [101] . PSs are components of a protein complex that proteolytically processes amyloid precursor protein into Ab peptides. The most popular hypothesis of AD is the 'amyloid hypothesis', whereby defective processing of amyloid precursor protein to Ab leads to the accumulation of Ab plaques and to AD pathology [102] . Also there is an opinion that toxic forms of Ab can induce Ca 2+ influx into neurons by inducing membrane-associated oxidative stress or by forming an oligomeric pore in the membrane, thereby rendering neurons vulnerable to excitotoxicity and apoptosis [103] .
Neuronal calcium signaling is dysregulated in AD [103] . Ca 2+ imaging experiments performed in Xenopus oocytes demonstrated that expression of FAD PS1 mutants potentiates IP 3 -mediated Ca 2+ release (Table 1 ) [104] . Enhanced IICR was also observed in Ca 2+ imaging experiments performed with cortical neurons from PS1 FAD mutant mice [105] . The mechanism responsible for these observations remains controversial. Our group suggested that PSs act as ER calcium leak channels, and FAD mutations in PSs disrupt this function, leading to ER Ca 2+ overload and excessive IICR [106, 107] . The function of PSs as ER Ca 2+ leak channels was supported by results of unbiased genetic screen for ER Ca 2+ modulators [108] . Another hypothesis is that gating of IP 3 R1 can be directly potentiated by FAD PSs [109, 110] . More recently it was shown that genetic reduction of IP 3 R1 normalizes disturbed calcium signaling in FAD PS1 mice and thus alleviates mutant PS-linked FAD pathogenesis [111] . The computational modeling of single IP 3 R activity was used to analyze and quantify the pathological enhancement of IP 3 R function by FADcausing mutant PS [112] . A combination of experimental data and computational modeling was used in further research for studying the differences in mitochondrial calcium influx in cells expressing WT and FAD-causing mutant PS [113] . Using experimental data on IICR, together with a computational model of cell bioenergetics, a data-driven Markov chain model for IP 3 R gating, and a model for the dynamics of the mitochondrial permeability transition pore (mPTP) the difference in mPTP opening in WT and mutant PS cells was shown. No mPTP opening occurred in control WT cells whereas mPTP opened in cells with mutant PS [113] . It was reasoned that mutant PS causes disturbed IICR that activates the mitochondrial calcium uniporter leading to the mPTP opening and eventually to cell death [113, 114] .
It appears that AD-linked Ab can also affect IP 3 R function. In Ca 2+ imaging experiments with DT40 cells and DT40 cells deficient in the three IP 3 R isoforms (DT40 TKO), the mechanisms of Ab-mediated Ca 2+ release from the ER were analyzed. Ab 42 -induced Ca 2+ release from the ER includes an Ab 42 sequence-specific component, which is IP 3 R-dependent, and another component, which is peptide sequenceand IP 3 R-independent [115] . The effect of Ab 42 oligomers on IICR was studied in astrocytes derived from the entorhinal cortex and from the hippocampus from WT and 39 Tg-AD transgenic mice [116] . The treatment of WT astrocytes with Ab 42 increased the expression of IP 3 R1 and mGluR5 in hippocampal astrocytes and provoked IICR only in hippocampal and not entorhinal cortex astrocytes. Treatment with Ab 42 did not affect IICR in astrocytes isolated from AD mice. Based on these results, the authors suggested that expression of AD-related mutant genes disturbs calcium signaling in astroglia. These experiments have shown that Ab 42 deregulates mGluR5 and the IP 3 R, the key elements of astrocytic calcium homeostasis. The effects of Ab 42 on calcium signaling in astrocytes were compared with the effects of pro-inflammatory agents such as tumor necrosis factor a, interleukin 1b and bacterial toxin lipopolysaccharide. Ab 42 induces store-operated calcium entry, while the other agents inhibited store-operated calcium entry. Treatment with Ab 42 significantly increased mRNA levels of IP 3 R1/2 and mGluR5, whereas pro-inflammatory agents reduced expression of those mRNAs [117] .
Studies with mouse cortical neurons showed that the extended treatment with Ab 42 oligomers selectively disrupts IICR since the amplitude of the intracellular calcium release in response to IP 3 -generating agonists (such as 3,5-dihydroxyphenylglycine) was decreasedwhereas in response to caffeine it was increased -compared with control neurons treated with monomeric form of Ab 42 . Conversely, no effect of synthetic Ab 42 oligomers on neuronal calcium store dynamics was observed in neurons during the acute application of Ab 42 . Thus, these data revealed disturbed ER calcium signaling in neurons exposed to Ab 42 oligomers and promote the potential use of the IP 3 R and RyR stabilizers in AD therapy [118] .
Experiments on primary cortical astrocyte cultures have revealed that an Ab neurotoxic fragment (Ab 25-35 ) provokes the dysregulation of calcium signaling and induces apoptosis in a concentration-dependent manner, leading to enhanced IICR. It was shown that treatment with the calcium chelator (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) reduced Ab-mediated apoptosis in astrocytes. Thus, it has been concluded that the Ab fragment modulates IP 3 R activity, increases IICR and leads to the apoptosis observed in AD [119] .
The AD pathology also involves mitochondrial toxicity that might be induced by Ab and its interference with N-methyl-D-aspartate (NMDA) receptors. Experiments on primary cortical neurons showed that treatment with Ab + NMDA significantly increased the intracellular calcium level and provoked immediate mitochondrial repolarization, when compared with Ab or NMDA alone. Pharmacological inhibition of the IP 3 R and the mitochondrial calcium uniporter revealed that Ab + NMDAinduced calcium increase involved IICR and mitochondrial calcium entry through the mitochondrial calcium uniporter [120] .
A recent study on SAD patients and patients with mild cognitive impairment (MCI), which is typical for the onset of AD, has shown that store-operated calcium entry and IICR are enhanced in the cytoplasm in unmodified B lymphocytes form MCI and SAD patients compared with control non-demented subjects. IP 3 R activation led to an increase in intracellular calcium level in SAD and MCI lymphocytes compared with non-demented subject cells. The basal intracellular calcium level was similar in SAD cells and nondemented subject cells, whereas MCI cells were characterized by higher basal cellular calcium level. The authors concluded that lymphocytes obtained from MCI patients may be promising for early SAD diagnosis [121] .
Overall, these results suggest that IP 3 R function is enhanced in variety of AD models and that inhibition of IP 3 R may help to prevent neuronal loss in AD.
Conclusion
The IP 3 R is involved in the control of key physiological processes, such as learning and memory, cell division and proliferation, differentiation, fertilization, development and cell death. Significant progress in understanding the structure and function of the IP 3 R has been achieved by the application of structural studies [23] . Dysfunction of the IP 3 R plays a key role in many neurodegenerative disorders, including HD, SCAs and AD. Disturbance of IP 3 R functions leads to deranged Ca 2+ signaling, and more often to enhanced IICR. Thus, the IP 3 R represents a potentially effective therapeutic target for treatment of neurodegenerative disorders by regulating the disturbed Ca 2+ signaling in affected brain regions.
There have already been attempts to suppress IICR in the context of neurodegenerative diseases. A chronic suppression of IICR was achieved by viral expression of IP 3 phosphatase in PCs of the SCA2-58Q mouse model. This alleviated the pathological phenotype in SCA2 mice, reduced neuronal cell death and improved motor coordination [90] . Moreover, IICR might be pharmacologically blocked with caffeine [122] and by therapeutic levels of lithium in the presence of neuronal calcium sensor-1 [123] . There are several other potential approaches to inhibit IICR in the context of neurodegeneration. Future studies will give us more details about the physiological functions of the IP 3 R in normal conditions and pathology and will provide new ways to search for treatment for incurable neurodegenerative diseases. 
